Pegah Ebrahimi

Director at Strand Therapeutics.

Raised on Strand Therapeutics filings

$108.1M

of $120.1M offered across 1 Form D filing

Form D filings: 1
Teammates: 6
Last filing: Mar 17, 2026

Company

Strand Therapeutics

Boston, MA

Programmable mRNA therapies for solid tumors

Programmable mRNA therapies for solid tumors

Investors: 10
Still open: $12M

Investors: 10
HQ: Boston, MA

Strand Therapeutics filings

Strand Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 17, 2026	Equity	$108.1M/ $120.1M	Form D

EquityFiled Mar 17, 2026Form D
$108.1M/ $120.1M

Works with

Also named on Strand Therapeutics filings

Jacob BecraftChief Executive Officer, Form D signerForm D signer Samta KunduExecutive Officer Ala AlenaziDirector Jeb KeiperDirector Jory BellDirector Tasuku KitadaExecutive Officer, Director, Promoter